The new council, comprising professionals from small or independent rheumatology practices, will work with the ACR and its committees on issues that confront members in small practices.

2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published
The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

Introducing Daniel F. Battafarano, DO, MACP, MACR, Chair of the ACR’s New Workforce Solutions Steering Committee
The new standing committee, devoted to addressing long-term workforce solutions in rheumatology, will be chaired by Daniel F. Battafarano, DO, MACP, MACR. Dr. Battafarano brings more than 35 years of leadership and experience in graduate medical education in rheumatology and internal medicine to the position.
Public Health Emergency Extended
Later this month, the Department of Health & Human Services (HHS) is expected to extend the public health emergency (PHE) for another 90 days. The PHE extension will allow for the continuation of many flexibilities instituted in 2020, including the expansion of such telehealth provisions as audio-only telehealth.
Gout & Excess Risk of Severe SARS-CoV-2 Infection
In this large, population-based study, Xie et al. found that the risks of SARS-CoV-2 infection, 30-day hospitalization and 30-day death were higher among individuals with gout than individuals without gout in the general population, irrespective of COVID-19 vaccination status.

Overcoming Healthcare Disparity
PHILADELPHIA—Quality improvement (QI) tools in pediatric rheumatology can help overcome health outcome disparities that are based on race, gender identity, income and other factors, experts said in a session at ACR Convergence. With it well established that these disparities exist, it’s time to begin eliminating them, said Emily Smitherman, MD, MS, assistant professor of pediatric…
FDA Officials Speak Out: New Approvals & Safety Concerns Discussed
PHILADELPHIA—Officials from the U.S. Food & Drug Administration discussed recent drug approvals and drug safety issues at ACR Convergence in November in a session that captured the flurry of activity in the rheumatology sphere at the agency over the past year. Sabiha Khan, MD, clinical reviewer in the Division of Rheumatology and Transplant Medicine at…
Mitigating Drug Shortages: FDA Officials Say Communication Is Crucial
PHILADELPHIA—The most vital component of avoiding drug shortages is early communication, officials from the U.S. Food & Drug Administration (FDA) said in a session at ACR Convergence 2022 in November. “Early notification is key in order to prevent and mitigate shortages,” said Hyun Son, PharmD, a member of the Drug Shortage Staff with the FDA…
Advocacy Is Central to Patient Care, Distinguished Lecturer Says
When she saw vaping taking hold at a middle school, Kamala Nola, PharmD, MS, spoke up about concerns for the students’ risk of rheumatic disease and other health issues. At ACR Convergence 2022, Dr. Nola emphasized that every healthcare professional can act as an advocate through everyday actions.

Insights into Methotrexate Toxicity in Elderly Patients with Rheumatic Disease
Data from a small study show that severe methotrexate toxicity in patients who are 70 years of age and older and have rheumatic disease may be associated with poor renal function and the use of diuretic treatments.
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 816
- Next Page »